Randox Biosciences: Molecular Biochip Arrays

Precise diagnostics for targeted therapy

Randox’s Molecular division offers diagnostic, prognostic and predictive solutions across a range of disease areas including sexually transmitted infections, respiratory tract infections, familial hypercholesterolemia (FH), colorectal cancer and cardiac risk prediction.

Utilising innovative Biochip Array Technology for multi-analyte screening of biological samples, Randox Molecular offers a range of molecular arrays and assay formats including SNP genotyping, gene expression, pathogen detection and mutation detection, across several key therapy areas, for clinical and research use.

Find out more click here